-
1 Comment
Drägerwerk AG & Co. KGaA is currently in a long term uptrend where the price is trading 13.7% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Drägerwerk AG & Co. KGaA's total revenue rose by 26.5% to $1B since the same quarter in the previous year.
Its net income has increased by 158.2% to $115M since the same quarter in the previous year.
Finally, its free cash flow grew by 383.8% to $328M since the same quarter in the previous year.
Based on the above factors, Drägerwerk AG & Co. KGaA gets an overall score of 5/5.
Sector | Healthcare |
---|---|
Industry | Medical Devices |
ISIN | DE0005550602 |
Exchange | F |
CurrencyCode | EUR |
PE Ratio | 7.32 |
---|---|
Target Price | None |
Beta | 0.28 |
Dividend Yield | 4.0% |
Market Cap | 971M |
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products include patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. In addition, the company offers alcohol and drug testing; fixed gas detectors; hazmat suits; portable gas detection; head protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply. Further, it provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for DRW8.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025